Cargando…
Evaluating the Safety of Medication Exposures During Pregnancy: A Case Study of Study Designs and Data Sources in Multiple Sclerosis
BACKGROUND: Regulatory agencies often request prospective, product-specific post-authorization pregnancy exposure registries to monitor safety during pregnancy, even though studies using existing health databases could also be employed. OBJECTIVES: Using multiple sclerosis (MS) as a case study, we e...
Autores principales: | Krueger, Whitney S., Anthony, Mary S., Saltus, Catherine W., Margulis, Andrea V., Rivero-Ferrer, Elena, Monz, Brigitta, Hirst, Ceri, Wormser, David, Andrews, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567459/ https://www.ncbi.nlm.nih.gov/pubmed/28756575 http://dx.doi.org/10.1007/s40801-017-0114-9 |
Ejemplares similares
-
Oseltamivir in pregnancy and birth outcomes
por: Ehrenstein, Vera, et al.
Publicado: (2018) -
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies
por: Roskell, Neil S., et al.
Publicado: (2013) -
Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero
por: Smith, Andrew L, et al.
Publicado: (2019) -
Treatment patterns in children with autism in the United States
por: Monz, Brigitta U., et al.
Publicado: (2019) -
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database
por: Johannes, Catherine B., et al.
Publicado: (2022)